Research Grid
Intelligently streamlining clinical operations and patient engagement from months to minutes.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | $6.5m | Seed | |
| Total Funding | 000k | ||
| USD | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 100 % | 13 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Research Grid is a company that has developed an AI-powered automation engine to streamline administrative tasks in clinical trials. The company's platform is designed to make clinical trials more efficient by automating back-office administration, which is a significant bottleneck in the drug development process.
Research Grid's main offerings are two products, Inclusive and TrialEngine, which together form an end-to-end platform for managing clinical trials. The company's software is used by medical research institutions to automate their administrative workflows. The business model is likely a B2B SaaS model, where clients pay for access to the platform.
The company operates in the healthcare technology market, specifically focusing on the clinical trial and drug development sector. By automating administrative tasks, Research Grid aims to reduce the time and cost associated with bringing new drugs to market. The company has recently secured $6.5 million in seed funding to support its growth and further development of its platform.
Keywords: clinical trials, AI-powered automation, drug development, back-office administration, healthcare technology, B2B SaaS, medical research, TrialEngine, Inclusive, administrative workflows